Cancer cytopathology is a vital field within cancer research, focusing on the microscopic examination of cells shed or collected from the body's surfaces. Through techniques like fine needle aspiration, experts can diagnose various cancers, determine their aggressiveness, and guide treatment decisions. This non-invasive approach allows for early detection, often before tumors are palpable. Advances in imaging technologies and molecular analysis have enhanced its precision, enabling the identification of specific genetic mutations and biomarkers crucial for personalized therapy. Furthermore, liquid biopsy, a promising avenue in cytopathology, offers a minimally invasive means to monitor treatment response and detect cancer recurrence. Overall, cancer cytopathology plays a pivotal role in improving patient outcomes by facilitating timely diagnosis and tailored treatment strategies.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States